1. Home
  2. BBCP vs ENGN Comparison

BBCP vs ENGN Comparison

Compare BBCP & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concrete Pumping Holdings Inc.

BBCP

Concrete Pumping Holdings Inc.

HOLD

Current Price

$6.82

Market Cap

356.0M

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$7.22

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBCP
ENGN
Founded
1983
1999
Country
United States
Canada
Employees
N/A
82
Industry
Engineering & Construction
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
356.0M
647.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BBCP
ENGN
Price
$6.82
$7.22
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$8.25
$21.00
AVG Volume (30 Days)
97.1K
521.9K
Earning Date
03-10-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,867,000.00
N/A
Revenue This Year
$3.49
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.04
$2.66
52 Week High
$7.80
$12.25

Technical Indicators

Market Signals
Indicator
BBCP
ENGN
Relative Strength Index (RSI) 51.54 33.99
Support Level $6.64 $6.18
Resistance Level $7.28 $7.33
Average True Range (ATR) 0.32 0.64
MACD -0.02 -0.10
Stochastic Oscillator 36.48 16.62

Price Performance

Historical Comparison
BBCP
ENGN

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators enables it to deliver concrete placement solutions. The company's operating segments include U.S. Concrete Pumping, U.K. Operations, and U.S. Concrete Waste Management Services, with the majority of revenue generated from the U.S. Concrete Pumping segment. Geographically, it operates in the United States and the United Kingdom, generating majority of its revenue from the United States.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: